We are live on ! Find out more
MG

Meditor Group Portfolio holdings

AUM $48.1M
1-Year Est. Return 38.67%
This Fund
S&P 500
This Quarter Est. Return
+2.13%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$133M
AUM Growth
+$5.84M
Cap. Flow
+$4.13M
Cap. Flow %
3.1%
Top 10 Hldgs %
100%
Holding
3
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
EXEL icon
Exelixis
EXEL
+$4.13M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXEL icon
1
Exelixis
EXEL
$13.9B
$64.6M 48.45%
19,070,213
+1,197,000
+7% +$4.13M
ALKS icon
2
Alkermes
ALKS
$8.82B
$51.9M 38.88%
1,030,639
VVUS
3
DELISTED
Vivus Inc
VVUS
$16.9M 12.67%
317,862

Similar funds

Meditor Group's Q2 2014 Portfolio in Review

As of Q2 2014, Meditor Group held 3 positions worth $133M, up 4.6% from $128M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Meditor Group deployed $4.13M of net new capital in Q2 2014, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Meditor Group added most to Exelixis in Q2 2014, an estimated $4.13M increase.
  • Meditor Group's ten largest holdings make up 100% of its $133M portfolio in Q2 2014.
  • Meditor Group opened 0 new positions and closed 0 in Q2 2014.
  • Meditor Group's portfolio value rose 4.6% quarter-over-quarter to $133M.

Based on Meditor Group's 13F filing for Q2 2014, filed 8 Jul 2014.